Adenosine a2a receptor antagonists for treating restless...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/522 (2006.01) A61K 31/00 (2006.01) A61P 25/14 (2006.01)

Patent

CA 2496920

The present invention provides methods of treating restless legs syndrome or related disorders, comprising administering an effective amount of at least one adenosine A2A receptor antagonist to a patient in need thereof. More preferably the adenosine A2A receptor antagonist is a xanthine derivative or a pharmaceutically acceptable salt thereof.

L'invention concerne des méthodes de traitement du syndrome des jambes sans repos ou de troubles associés consistant à administrer une quantité efficace d'au moins un antagoniste du récepteur A¿2A? de l'adénosine à un patient nécessitant une telle administration. Idéalement, l'antagoniste du récepteur A¿2A? de l'adénosine est un dérivé de la xanthine ou un sel acceptable sur le plan pharmaceutique de celui-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Adenosine a2a receptor antagonists for treating restless... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adenosine a2a receptor antagonists for treating restless..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine a2a receptor antagonists for treating restless... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1346965

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.